MELK and prostate cancer: Furthermore, in the Cambridge and Stockholm datasets, MELK is among a list of 100 strongest genes that stratify prostate cancers into distinct molecular subgroups with different clinical outcomes based on integration of copy number and transcript data from radical prostatectomy specimens (Ross‐Adams et al, 2015).